Eckert & Ziegler SE (ETR:EUZ)
14.50
+0.57 (4.09%)
Nov 12, 2026, 5:35 PM CET
Eckert & Ziegler SE Revenue
Eckert & Ziegler SE had revenue of 79.62M EUR in the quarter ending September 30, 2026, with 5.72% growth. This brings the company's total for the last twelve months to 316.81M, up 4.05% year-over-year. In the year 2025, Eckert & Ziegler SE had annual revenue of 311.96M with 5.45% growth. That makes Eckert & Ziegler SE the 13,540th largest company in the world by revenue and 250th in Germany.
Revenue (ttm)
316.81M
Revenue Growth
+4.05%
P/S Ratio
2.86
Revenue / Employee
286.70K
Employees
1,105
Market Cap
907.36M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Eckert & Ziegler SE breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 311.96M | 16.11M | 5.45% |
| Dec 31, 2024 | 295.85M | 49.76M | 20.22% |
| Dec 31, 2023 | 246.09M | 23.86M | 10.74% |
| Dec 31, 2022 | 222.23M | 41.79M | 23.16% |
| Dec 31, 2021 | 180.44M | 4.30M | 2.44% |
| Dec 31, 2020 | 176.14M | -2.35M | -1.32% |
| Dec 31, 2019 | 178.49M | 9.78M | 5.80% |
| Dec 31, 2018 | 168.71M | 30.08M | 21.70% |
| Dec 31, 2017 | 138.63M | 18.76M | 15.65% |
| Dec 31, 2016 | 119.87M | -19.88M | -14.22% |
| Dec 31, 2015 | 139.75M | 12.49M | 9.82% |
| Dec 31, 2014 | 127.26M | 10.12M | 8.64% |
| Dec 31, 2013 | 117.14M | -2.86M | -2.38% |
| Dec 31, 2012 | 120.00M | 3.80M | 3.27% |
| Dec 31, 2011 | 116.20M | 5.10M | 4.59% |
| Dec 31, 2010 | 111.09M | 9.69M | 9.56% |
| Dec 31, 2009 | 101.40M | 29.79M | 41.59% |
| Dec 31, 2008 | 71.61M | 17.17M | 31.53% |
| Dec 31, 2007 | 54.44M | 4.07M | 8.07% |
| Dec 31, 2006 | 50.38M | 8.59M | 20.54% |
| Dec 31, 2005 | 41.79M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.77B |
| Siemens Healthineers AG | 23.63B |
| Fresenius SE & Co. KGaA | 23.61B |
| Merck KGaA | 21.14B |
| Drägerwerk AG & Co. KGaA | 3.59B |
| Redcare Pharmacy NV | 3.34B |
| Gerresheimer AG | 2.32B |
| RHÖN-KLINIKUM Aktiengesellschaft | 2.06B |
Eckert & Ziegler SE News
- 5 hours ago - Pentixapharm Extends €18.5 Mln Convertible Bond To 2030, Raises Interest Rate - Nasdaq
- 10 hours ago - Eckert & Ziegler SE Quarterly report: Q3 2026 - Filings
- 10 hours ago - Eckert & Ziegler SE Slides: Q3 2026 - Filings
- 12 hours ago - EQS-Adhoc: Pentixapharm Holding AG extends drawdown period and term of its convertible bond with Eckert & Ziegler SE to 2030 with adjusted terms - Wallstreet:Online
- 14 hours ago - Eckert & Ziegler: Q3 Adjusted EBIT Soars 25%; 2026 Forecast Confirmed - Wallstreet:Online
- 4 weeks ago - Eckert & Ziegler, TerThera Sign Tb-161 Supply Deal For Cancer Therapies In Brazil - Nasdaq
- 7 weeks ago - EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 7 weeks ago - Eckert & Ziegler SE Slides: Investor presentation - Filings